71467-5
Erythropoiesis-stimulating agent prescribed Medication
Trial
Status Information
- Status
- TRIAL
Fully-Specified Name
- Component
- Erythropoiesis-stimulating agent prescribed
- Property
- Find
- Time
- Pt
- System
- Medication
- Scale
- Nom
- Method
Survey Question
- Source
- ESRD.RQMT_976&1220
Normative Answer List: LL2104-9
Source: Centers for Medicare & Medicaid Services| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Epoetin Alfa | LA18620-7 | ||
| Epoetin Beta | LA18621-5 | ||
| Darbepoetin Alfa | LA18622-3 | ||
| Other | LA46-8 |
Basic Attributes
- Class
- SURVEY.ESRD
- Type
- Surveys
- First Released
- Version 2.40
- Last Updated
- Version 2.67
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 71457-6 | Erythropoiesis-stimulating agent panel [ESRD] |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=71467-5
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright